These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis. Dana B; Carvalho AC; Ellman L Am J Clin Pathol; 1976 Jun; 65(6):964-9. PubMed ID: 945687 [TBL] [Abstract][Full Text] [Related]
8. [Studies on the platelet factor 4. I. Relationship of Pf 4 to haemorrhage (author's transl)]. Matsuoka M; Hoshiyama M; Shinada S; Sakuragawa N Rinsho Ketsueki; 1975 Oct; 16(10):936-45. PubMed ID: 1239528 [No Abstract] [Full Text] [Related]
9. Platelet consumption and plasma concentration of platelet factor 4 (PF-J). Gjesdal K; Abrahamsen AF Scand J Haematol; 1976 Jul; 17(1):5-9. PubMed ID: 959773 [TBL] [Abstract][Full Text] [Related]
10. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)]. Sakuragawa N; Takahashi K; Hoshiyama M; Matsuoka M Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):218-26. PubMed ID: 578067 [No Abstract] [Full Text] [Related]
11. [Determination of platelest factor III. (Total content and availability)]. Scrobohaci ML Med Interna (Bucur); 1974 May; 26(5):623-32. PubMed ID: 4526294 [No Abstract] [Full Text] [Related]
12. [A basic and clinical study on platelet factor 4 (PF4)]. Satoh M; Endo Y; Mamiya S Rinsho Byori; 1982 Jun; 30(6):673-7. PubMed ID: 7131839 [No Abstract] [Full Text] [Related]
13. [Changes in the anti-heparin activity of platelet-free plasma in rats with induced inflammation and after administration of CC14 (author's transl)]. Pospísil J; Klír P Sb Lek; 1982 Mar; 84(3):77-84. PubMed ID: 7089473 [No Abstract] [Full Text] [Related]
14. [Effect of retinal vein thrombosis and coagulation factors in young adults (author's transl)]. Saraux H; Dupuy E; Caen J J Fr Ophtalmol; 1982; 5(2):125-7. PubMed ID: 7077046 [TBL] [Abstract][Full Text] [Related]
15. [Studies on thrombopoietin. I. Purification and properties of thrombopoietin and immunological assay for serum thrombopoietin in thrombopenic and thrombocytoic patients (author's transl)]. Ashizawa T Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):483-95. PubMed ID: 495008 [No Abstract] [Full Text] [Related]
16. A radioimmunoassay for platelet factor 4. Bolton AE; Ludlam CA; Pepper DS; Moore S; Cash JD Thromb Res; 1976 Jan; 8(1):51-8. PubMed ID: 1251342 [No Abstract] [Full Text] [Related]
17. [Plasma beta-thromboglobulin level in thromboembolic diseases: a marker of in-vivo platelet release reaction]. Modiano A G Clin Med; 1980 Sep; 61(9):672-8. PubMed ID: 6162700 [No Abstract] [Full Text] [Related]
18. Lack of release of platelet factor 4 during exercise-induced myocardial ischemia. Mathis PC; Wohl H; Wallach SR; Engler RL N Engl J Med; 1981 May; 304(21):1275-8. PubMed ID: 7219473 [No Abstract] [Full Text] [Related]
19. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. Zucker S; Mielke CH J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386 [No Abstract] [Full Text] [Related]
20. Platelet markers of thromboembolic disease. Wohl H West J Med; 1981 Jul; 135(1):19-24. PubMed ID: 6167074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]